Robert E. Lovelace

7.2k total citations
93 papers, 5.1k citations indexed

About

Robert E. Lovelace is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert E. Lovelace has authored 93 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Neurology, 30 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in Robert E. Lovelace's work include Peripheral Neuropathies and Disorders (24 papers), Hereditary Neurological Disorders (19 papers) and Botulinum Toxin and Related Neurological Disorders (12 papers). Robert E. Lovelace is often cited by papers focused on Peripheral Neuropathies and Disorders (24 papers), Hereditary Neurological Disorders (19 papers) and Botulinum Toxin and Related Neurological Disorders (12 papers). Robert E. Lovelace collaborates with scholars based in United States, Canada and Italy. Robert E. Lovelace's co-authors include Lewis P. Rowland, Stanley Fahn, Dale J. Lange, Mitchell F. Brin, Audrey S. Penn, Andrew Blitzer, Arthur P. Hays, David S. Younger, Alfred Jaretzki and Antonino Uncini and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Brain.

In The Last Decade

Robert E. Lovelace

89 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Lovelace United States 41 3.0k 1.3k 949 915 871 93 5.1k
Shin J. Oh United States 38 2.7k 0.9× 1.2k 1.0× 1.4k 1.5× 613 0.7× 676 0.8× 128 5.4k
F.G.I. Jennekens Netherlands 40 1.6k 0.5× 1.9k 1.5× 1.2k 1.3× 383 0.4× 652 0.7× 132 4.8k
Henry C. Powell United States 41 851 0.3× 2.1k 1.6× 767 0.8× 1.3k 1.4× 1.3k 1.5× 107 4.7k
Uros Roessmann United States 38 1.1k 0.4× 767 0.6× 1.0k 1.1× 458 0.5× 400 0.5× 112 4.2k
Yoshigoro Kuroiwa Japan 36 1.7k 0.6× 891 0.7× 1.5k 1.6× 278 0.3× 605 0.7× 211 4.6k
Antonino Uncini Italy 45 4.0k 1.3× 3.1k 2.5× 818 0.9× 719 0.8× 579 0.7× 178 6.2k
Giuseppe Vita Italy 37 1.1k 0.4× 1.1k 0.9× 2.5k 2.6× 611 0.7× 740 0.8× 245 5.5k
Tanya Stojkovic France 42 1.7k 0.6× 1.5k 1.1× 2.2k 2.3× 350 0.4× 724 0.8× 200 5.3k
Christian Krarup Denmark 35 1.2k 0.4× 2.1k 1.7× 572 0.6× 1.0k 1.1× 448 0.5× 137 4.0k
Simmons Lessell United States 38 1.9k 0.6× 316 0.2× 697 0.7× 660 0.7× 430 0.5× 183 4.6k

Countries citing papers authored by Robert E. Lovelace

Since Specialization
Citations

This map shows the geographic impact of Robert E. Lovelace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Lovelace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Lovelace more than expected).

Fields of papers citing papers by Robert E. Lovelace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Lovelace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Lovelace. The network helps show where Robert E. Lovelace may publish in the future.

Co-authorship network of co-authors of Robert E. Lovelace

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Lovelace. A scholar is included among the top collaborators of Robert E. Lovelace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Lovelace. Robert E. Lovelace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lovelace, Robert E.. (2006). A tribute to Jack Petajan's inspiration: From goat to goat. Journal of the Neurological Sciences. 242(1-2). 43–46.
2.
Weimer, Louis H., et al.. (2002). The utility of segmental nerve conduction studies in ulnar mononeuropathy at the elbow. Muscle & Nerve. 27(1). 46–50. 42 indexed citations
3.
Kamholz, John, et al.. (1999). Charcot-Marie-Tooth disorders. New York Academy of Sciences eBooks. 4 indexed citations
4.
Shy, Michael E., John Kamholz, & Robert E. Lovelace. (1999). Introduction to the Third International Symposium on Charcot‐Marie‐Tooth Disorders. Annals of the New York Academy of Sciences. 883(1). xiii–xviii. 6 indexed citations
5.
Roa, Benjamin B., Laura E. Warner, Carlos A. Garcia, et al.. (1996). Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Human Mutation. 7(1). 36–45. 57 indexed citations
6.
Berg, Leonard H. van den, Arthur P. Hays, Eduardo Nobile‐Orazio, et al.. (1996). Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle & Nerve. 19(5). 637–643. 88 indexed citations
7.
Hirano, Michio, Gabriella Silvestri, Anne Lombès, et al.. (1994). Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neurology. 44(4). 721–721. 310 indexed citations
8.
Moraes, Carlos T., E. Bonilla, Christer T. Jansén, et al.. (1993). Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot?. Journal of Clinical Investigation. 92(6). 2906–2915. 175 indexed citations
9.
Cafferty, Maureen, et al.. (1991). Polyglucosan body disease. Muscle & Nerve. 14(2). 102–107. 43 indexed citations
10.
Younger, David S., Lewis P. Rowland, N. Latov, et al.. (1991). Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Annals of Neurology. 29(1). 78–86. 95 indexed citations
11.
Uncini, Antonino, et al.. (1990). Long‐duration polyphasic motor unit potentials in myopathies: A quantitative study with pathological correlation. Muscle & Nerve. 13(3). 263–267. 52 indexed citations
12.
Lovelace, Robert E.. (1990). Hereditary Induced Peripheral Neuropathies. Clinics in Podiatric Medicine and Surgery. 7(1). 37–50. 2 indexed citations
13.
Younger, David S., et al.. (1989). Recurrent myoglobinuria and HIV seropositivity: Incidental or pathogenic association?. Muscle & Nerve. 12(10). 842–843. 17 indexed citations
14.
Brin, Mitchell F., Andrew Blitzer, Stanley Fahn, Robert E. Lovelace, & Wilbur J. Gould. (1989). Adductor laryngeal dystonia (spastic dysphonia): Treatment with local injections of botulinum toxin (Botox). Movement Disorders. 4(4). 287–296. 67 indexed citations
15.
Cafferty, Maureen, et al.. (1989). Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. The American Journal of Medicine. 87(5). 553–557. 65 indexed citations
16.
Jaretzki, Alfred, Audrey S. Penn, David S. Younger, et al.. (1988). “Maximal” thymectomy for myasthenia gravis. Journal of Thoracic and Cardiovascular Surgery. 95(5). 747–757. 167 indexed citations
17.
Soliven, Betty, Jacob Meer, Antonino Uncini, Jack H. Petajan, & Robert E. Lovelace. (1988). Physiologic and anatomic basis for contralateral R1 in blink reflex. Muscle & Nerve. 11(8). 848–851. 12 indexed citations
18.
Uncini, Antonino, Seth L. Pullman, Robert E. Lovelace, & D. Gambi. (1988). The sympathetic skin response: Normal values, elucidation of afferent components and application limits. Journal of the Neurological Sciences. 87(2-3). 299–306. 118 indexed citations
19.
Brin, Mitchell F., Stanley Fahn, Carol Moskowitz, et al.. (1987). Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Movement Disorders. 2(4). 237–254. 321 indexed citations
20.
Lovelace, Robert E., et al.. (1954). RESISTANT VENTRICULAR TACHYCARDIA CURED WITH LARGE DOSES OF PROCAINAMIDE. The Lancet. 263(6819). 957–959.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin J. Oh Breakdown of academic impact, for papers by F.G.I. Jennekens Breakdown of academic impact, for papers by Henry C. Powell Breakdown of academic impact, for papers by Uros Roessmann Breakdown of academic impact, for papers by Yoshigoro Kuroiwa Breakdown of academic impact, for papers by Antonino Uncini Breakdown of academic impact, for papers by Giuseppe Vita Breakdown of academic impact, for papers by Tanya Stojkovic Breakdown of academic impact, for papers by Christian Krarup Breakdown of academic impact, for papers by Simmons Lessell
Rankless by CCL
2026